Log in to view video content

Transcript

Poštovani kolege, poštovani građani,
Stotine milijona građana diljem svijeta
u posljednje dva dana je putem društvenih mreža vidjelo odgovor direktora Pfizera
na pitanje kolege Roba Rossa.
Je li provedeno testiranje cijepiva na spričavanje prijenosa virusa?
Dobio je izravan odgovor.
Nije provedeno.
Dakle, uopće nije provedeno testiranje cijepiva na prijenos virusa.
Nadalje, s obzirom da iz drugih dostupnih podataka,
pogotovo podataka engleskog NHS-a,
koji precizno vodi statistiku oboljelih, hospitaliziranih i umrlih
prema tzv. cijepnom statusu 1., 2., 3. i 4. doze i necijepljenih,
nedvojbeno proizlazi da ne postoji razlika u zarazi, oboljevanju i umiranju od COVID-19
između tzv. cijepljenih i necijepljenih građana.
Sljedom toga, nužno je odmah raskinuti ugovor o nabavci danjih doza,
koji nam prodali lažna cijepiva,
zatražiti povrat dosad uplačenih sredstava
u iznosu od 2,5 milijarde euro
te pokrenutni kazneni progon proti Pfizer-a i drugih.
U suprotnom, i sami sudjelujemo u vršenju kaznenog dijela nabavke
i promoviranja lažnih ljekova
te uništenju proračuna Europske unije u visini od 71 milijarde euro.
Ukoliko i zakoliko se Ursuna Folden Line obvezala u ime svih nas platiti farmaceutima?
Moje pitanje je, kad ćete raskinuti ugovor? Hvala.
Past 31 days
Total Visit: 0
There is 1 fact-checking reply to the message
Ann mark this message contains misinformation
originally written by Ann
部分錯誤。影片中的講者為克羅埃西亞歐洲議會議員Mislav Kolakušić,其對於英國疫苗數據的解讀,含有錯誤資訊,但指稱輝瑞因沒有提出防止人際傳播的疫苗數據,應該返還預算等內容,則為個人意見。

1. 英國國家統計局(ONS)數據及衛生安全局(UKHSA)對疫苗有效性的監測,已顯示接種COVID-19疫苗能降低重症與死亡率。
根據英國確診死亡與接種狀態的分析,各年齡層中,接種三劑疫苗的死亡率確實低於未接種或接種兩劑以下者。研究也指出,輝瑞加強劑對於重症、住院能提供97%至99%的保護力。影片提及英國相關數據「完全不因接種疫苗有所差別」,為錯誤資訊。

2. 輝瑞國際市場總裁Janine Small確實表示,疫苗上市前未研究其是否能阻止病毒傳播,但疫苗臨床測試的用意,本來就只在於確認預防疾病與重症的功效,而非「阻止傳播」。Kolakušić認為歐盟應終止合約、輝瑞應返還預算等內容,僅為個人意見。

(1)埃默里大學疫苗中心副主任Walter Orenstein博士表示,「傳播」是複雜的衡量指標,輝瑞在臨床試驗期間沒有研究疫苗對傳播的影響並非特例。

(2)輝瑞自始沒有聲稱病毒能阻止傳播。美國FDA於2020年12月11日通過疫苗授權的新聞稿,也明白表示「目前,沒有數據可以確定疫苗將提供多長時間的保護,也沒有證據表明該疫苗可防止SARS-CoV-2在人與人之間傳播。」

(3) 費城兒童醫院疫苗教育中心主任Paul Offit指出:「當你接種疫苗,將明顯降低你被感染的機率,因此也會降低你將其傳播給他人的機會」,雖不能保證消除所有的傳播,但疫苗上市後的研究確實發現,輝瑞疫苗有助於減少alpha和delta變種的傳播。

References

英國衛生安全局(UKHSA):Monitoring reports of the effectiveness of COVID-19 vaccination
https://www.gov.uk/guidance/monitoring-reports-of-the-effectiveness-of-covid-19-vaccination

英國國家統計局(ONS):Deaths involving COVID-19 by vaccination status, England: deaths occurring between 1 January 2021 and 31 May 2022
https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsinvolvingcovid19byvaccinationstatusengland/deathsoccurringbetween1january2021and31may2022

Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England
https://www.nature.com/articles/s41591-022-01699-1

Posts mislead on Pfizer COVID vaccine’s impact on transmission
https://apnews.com/article/fact-check-pfizer-transmission-european-parliament-950413863226

politifact: Pfizer executive “admits” vaccine was never tested for preventing transmission.
https://www.politifact.com/factchecks/2022/oct/13/instagram-posts/alleged-revelation-about-pfizer-vaccine-trial-noth/

Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants
https://www.nejm.org/doi/full/10.1056/nejmoa2116597#:~:text=Conclusions,only partially explained decreased transmission.

FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine
https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19

Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England

Nature Medicine - A test-negative case–control analysis of data from the National Immunisation Management System in England demonstrates significant levels of increased protection against...

https://www.nature.com/articles/s41591-022-01699-1

The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.

Add Cofacts as friend in LINE
Add Cofacts as friend in LINE
LINE 機器人
查謠言詐騙